Total Payments
$884.21
2023 Payments
$17.03
Companies
16
Transactions
65
Medicare Patients
1,980
Medicare Billing
$231,079
Payment Breakdown by Category
Food & Beverage$884.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $884.21 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $257.72 | 24 | $0 (2020) |
| Allergan, Inc. | $178.22 | 9 | $0 (2020) |
| Amgen Inc. | $80.82 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $77.36 | 6 | $0 (2020) |
| Amarin Pharma Inc. | $55.26 | 4 | $0 (2020) |
| Astellas Pharma US Inc | $37.96 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $32.44 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $32.07 | 2 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $27.26 | 4 | $0 (2017) |
| Lilly USA, LLC | $24.70 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.03 | 1 | Janssen Pharmaceuticals, Inc ($17.03) |
| 2022 | $15.09 | 1 | E.R. Squibb & Sons, L.L.C. ($15.09) |
| 2021 | $16.98 | 1 | E.R. Squibb & Sons, L.L.C. ($16.98) |
| 2020 | $354.06 | 23 | Novo Nordisk Inc ($149.67) |
| 2017 | $481.05 | 39 | Allergan Inc. ($148.45) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Cardiovascular | ||||||
| 11/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Diabetes | ||||||
| 11/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 10/13/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Respiratory | ||||||
| 10/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Diabetes | ||||||
| 10/02/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 09/24/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular | ||||||
| 09/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
| 08/21/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Bone Health | ||||||
| 08/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Cardiovascular | ||||||
| 08/19/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 08/07/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 07/20/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 07/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiovascular | ||||||
| 07/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular | ||||||
| 06/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Diabetes | ||||||
| 06/02/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Bone Health | ||||||
| 05/28/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: UROLOGY | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 624 | 1,216 | $308,660 | $91,958 |
| 2022 | 7 | 648 | 1,330 | $327,253 | $89,121 |
| 2021 | 9 | 318 | 578 | $128,754 | $36,679 |
| 2020 | 8 | 390 | 472 | $45,082 | $13,322 |
Total Patients
1,980
Total Services
3,596
Medicare Billing
$231,079
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 211 | 642 | $121,980 | $37,742 | 30.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 135 | 284 | $79,520 | $25,162 | 31.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 141 | 148 | $39,960 | $12,577 | 31.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 93 | $50,220 | $12,002 | 23.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 19 | $11,970 | $3,003 | 25.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $3,060 | $969.26 | 31.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 13 | $1,950 | $501.54 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 220 | 739 | $142,498 | $38,417 | 27.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 295 | $84,820 | $22,518 | 26.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 88 | 90 | $48,600 | $13,304 | 27.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 89 | 92 | $24,840 | $7,192 | 29.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 61 | 62 | $11,985 | $3,330 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Office | 2022 | 20 | 20 | $9,380 | $2,944 | 31.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 20 | 21 | $3,150 | $830.78 | 26.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $1,980 | $585.05 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 231 | $43,890 | $12,571 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 149 | $41,720 | $11,659 | 27.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $18,360 | $5,154 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 38 | $5,284 | $1,972 | 37.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 23 | 24 | $6,480 | $1,930 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 36 | $7,707 | $1,906 | 24.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 23 | 24 | $4,320 | $1,308 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 22 | 31 | $766.32 | $93.00 | 12.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 11 | 11 | $226.60 | $85.47 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 109 | $22,982 | $7,844 | 34.1% |
About Dr. Matthew Humpal, M.D
Dr. Matthew Humpal, M.D is a Family Medicine healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2012. The National Provider Identifier (NPI) number assigned to this provider is 1609135375.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Humpal, M.D has received a total of $884.21 in payments from pharmaceutical and medical device companies, with $17.03 received in 2023. These payments were reported across 65 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($884.21).
As a Medicare-enrolled provider, Humpal has provided services to 1,980 Medicare beneficiaries, totaling 3,596 services with total Medicare billing of $231,079. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location South Sioux City, NE
- Active Since 05/15/2012
- Last Updated 02/21/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609135375
Products in Payments
- Ozempic (Drug) $140.13
- DALVANCE (Drug) $103.52
- Victoza (Drug) $95.51
- Vascepa (Drug) $55.26
- FARXIGA (Drug) $46.15
- EVENITY (Biological) $33.58
- JANUVIA (Drug) $32.44
- ELIQUIS (Drug) $32.07
- UBRELVY (Drug) $29.77
- Prolia (Biological) $26.08
- TRULICITY (Drug) $24.70
- Myrbetriq (Drug) $23.15
- Tresiba (Drug) $22.08
- Aimovig (Biological) $21.16
- BREZTRI AEROSPHERE (Drug) $17.37
- XARELTO (Drug) $17.03
- TEFLARO (Drug) $16.88
- CONTRAVE (Drug) $16.46
- LINZESS (Drug) $16.40
- MYRBETRIQ (Drug) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Sioux City
Dr. Michael Brenner, M.d, M.D
Family Medicine — Payments: $17,646
Family Medicine $17,646
Michael Hattan, Md, MD
Family Medicine — Payments: $11,240
Family Medicine $11,240
Thomas Wente, Do, DO
Family Medicine — Payments: $10,128
Family Medicine $10,128
Melissa Austreim-Krell, M.d, M.D
Family Medicine — Payments: $8,652
Family Medicine $8,652
David Ensz, M.d, M.D
Family Medicine — Payments: $7,676
Family Medicine $7,676
Suhair Najdawi, Md, MD
Family Medicine — Payments: $4,040
Family Medicine $4,040